CNTX
Price
$1.48
Change
-$0.04 (-2.63%)
Updated
Jan 16, 11:16 AM (EDT)
Capitalization
139.66M
68 days until earnings call
Intraday BUY SELL Signals
ZURA
Price
$4.92
Change
+$0.22 (+4.69%)
Updated
Jan 16, 12:03 PM (EDT)
Capitalization
304.96M
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTX vs ZURA

Header iconCNTX vs ZURA Comparison
Open Charts CNTX vs ZURABanner chart's image
Context Therapeutics
Price$1.48
Change-$0.04 (-2.63%)
Volume$300
Capitalization139.66M
Zura Bio
Price$4.92
Change+$0.22 (+4.69%)
Volume$1.7K
Capitalization304.96M
CNTX vs ZURA Comparison Chart in %
CNTX
Daily Signal:
Gain/Loss:
ZURA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTX vs. ZURA commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Hold and ZURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (CNTX: $1.52 vs. ZURA: $4.69)
Brand notoriety: CNTX and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 86% vs. ZURA: 205%
Market capitalization -- CNTX: $139.66M vs. ZURA: $304.96M
CNTX [@Biotechnology] is valued at $139.66M. ZURA’s [@Biotechnology] market capitalization is $304.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whileZURA’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • ZURA’s FA Score: 0 green, 5 red.
According to our system of comparison, ZURA is a better buy in the long-term than CNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 6 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • CNTX’s TA Score: 6 bullish, 4 bearish.
  • ZURA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CNTX is a better buy in the short-term than ZURA.

Price Growth

CNTX (@Biotechnology) experienced а -5.00% price change this week, while ZURA (@Biotechnology) price change was -10.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +41.99%.

Reported Earning Dates

CNTX is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZURA($305M) has a higher market cap than CNTX($140M). CNTX YTD gains are higher at: 3.401 vs. ZURA (-10.496). CNTX has higher annual earnings (EBITDA): -30.19M vs. ZURA (-72.53M). ZURA has more cash in the bank: 139M vs. CNTX (76.9M). CNTX (0) and ZURA (0) have equivalent revenues.
CNTXZURACNTX / ZURA
Capitalization140M305M46%
EBITDA-30.19M-72.53M42%
Gain YTD3.401-10.496-32%
P/E RatioN/A7.96-
Revenue00-
Total Cash76.9M139M55%
Total Debt140KN/A-
TECHNICAL ANALYSIS
Technical Analysis
CNTXZURA
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
48%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
57%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
61%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
53%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 25 days ago
88%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
51%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
CNTX
Daily Signal:
Gain/Loss:
ZURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXTDF0.120.02
+14.85%
NextGen Digital Platforms Inc.
HPQFF0.140.01
+5.49%
HPQ SILICON INC
CMTDF32.25N/A
N/A
Sumitomo Mitsui Trust Group, Inc.
GLAPY87.00N/A
N/A
Glanbia Plc
SPSTF0.32N/A
N/A
Singapore Post, Ltd.

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and ZURA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and ZURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-3.18%
ZURA - CNTX
31%
Poorly correlated
-12.66%
PROK - CNTX
29%
Poorly correlated
-4.39%
CRBP - CNTX
28%
Poorly correlated
-1.09%
PRQR - CNTX
28%
Poorly correlated
-3.66%
NAMS - CNTX
28%
Poorly correlated
-0.28%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with FATE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
-12.66%
FATE - ZURA
46%
Loosely correlated
-2.78%
VIR - ZURA
43%
Loosely correlated
-9.09%
CRBU - ZURA
42%
Loosely correlated
-3.11%
SYRE - ZURA
40%
Loosely correlated
-0.21%
CGON - ZURA
39%
Loosely correlated
-4.40%
More